These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 29734149)
21. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study. Moroni G; Raffiotta F; Trezzi B; Giglio E; Mezzina N; Del Papa N; Meroni P; Messa P; Sinico AR Rheumatology (Oxford); 2014 Sep; 53(9):1570-7. PubMed ID: 24505125 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis. Ikeuchi H; Hiromura K; Takahashi S; Mishima K; Sakurai N; Sakairi T; Kaneko Y; Maeshima A; Kuroiwa T; Nojima Y Mod Rheumatol; 2014 Jul; 24(4):618-25. PubMed ID: 24252014 [TBL] [Abstract][Full Text] [Related]
23. [Treatment of systemic lupus erythematosus: myths, certainties and doubts]. Ruiz-Irastorza G; Danza A; Khamashta M Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892 [TBL] [Abstract][Full Text] [Related]
24. The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis. Zhang X; Ji L; Yang L; Tang X; Qin W Int Urol Nephrol; 2016 May; 48(5):731-43. PubMed ID: 26781720 [TBL] [Abstract][Full Text] [Related]
25. Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis. Cooper JC; Rouster-Stevens K; Wright TB; Hsu JJ; Klein-Gitelman MS; Ardoin SP; Schanberg LE; Brunner HI; Eberhard BA; Wagner-Weiner L; Mehta J; Haines K; McCurdy DK; Phillips TA; Huang Z; von Scheven E; Pediatr Rheumatol Online J; 2018 Oct; 16(1):65. PubMed ID: 30348175 [TBL] [Abstract][Full Text] [Related]
26. B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments. Yap DYH; Chan TM Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835612 [TBL] [Abstract][Full Text] [Related]
27. Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis. Li X; Ren H; Zhang Q; Zhang W; Wu X; Xu Y; Shen P; Chen N Nephrol Dial Transplant; 2012 Apr; 27(4):1467-72. PubMed ID: 21917733 [TBL] [Abstract][Full Text] [Related]
28. Lupus nephritis: maintenance therapy for lupus nephritis--do we now have a plan? Lenz O; Waheed AA; Baig A; Pop A; Contreras G Clin J Am Soc Nephrol; 2013 Jan; 8(1):162-71. PubMed ID: 22917704 [TBL] [Abstract][Full Text] [Related]
29. [Treatment of lupus nephritis]. Novak S Lijec Vjesn; 2014; 136(7-8):215-9. PubMed ID: 25327009 [TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of tacrolimus for the treatment of moderate-to-severe lupus nephritis in China. Kim S; Reen Ooi AY; Stephens T; Jiang H J Comp Eff Res; 2019 Oct; 8(13):1125-1141. PubMed ID: 31580156 [No Abstract] [Full Text] [Related]